In this episode of Don't Miss a Beat, hosts Drs. Greene and Vaduganathan break down the new ACC/AHA/HFSA heart failure guidelines debuted at ACC.22 and compare the recommendations against those made in the European Society of Cardiology's 2021 heart failure guidelines.

Headed to ACC.22 this weekend or following along virtually? Get the weekend started with our special ACC.22 preview edition of Don't Miss a Beat. Hear from co-hosts Drs. Vaduganathan and Greene on their top picks from the late-breaking sessions at the upcoming American College of Cardiology meeting and offer their thoughts on the recent EMPA-KIDNEY announcement. 

Dr. Eugene Braunwald joins Don't Miss a Beat hosts Dr. Greene and Dr. Vaduganathan to provide perspective on founding the TIMI study group, how trials have evolved, and advice he would give to young professionals interested in becoming trialists.

Join Dr. Steve Greene and Dr. Muthiah Vaduganathan for a regular news roundup of the latest evidence and clinical trial insights across cardiovascular, renal, and metabolic diseases. In the inaugural episode of Don't Miss a Beat, Drs. Greene and Vaduganathan discuss the impact of an early career mentor and provide insight into their favorite trials from 2021, including EMPEROR-Preserved and SSaSS. A video version of this podcast, which includes visual aids, can be found on PracticalCardiology.com

Based on a study she presented at ACC.21, Laxmi Mehta, MD, discusses COVID-19 and burnout among cardiology professionals with Practical Cardiology senior editor Patrick Campbell.  This conversation has been edited for time and clarity.

In this episode, Dr. Stephen Greene, of the Duke Clinical Research Institute, breaks down a recent study he led comparing the sensitivity of NYHA class versus patient-reported outcomes for capturing changes in disease state among patients with HFrEF.

In this special National Wear Red Day edition of Inside Cardiology, we speak with Jennifer Majersik, MD, about a special edition of the Stroke journal highlighting disparities in stroke care for women. 

Prof. Kausik Ray discusses inclisiran data from the ORION program presented at ESC Congress 2020 and examines whether clinicians should feel comfortable prescribing the agents based on clinical trial data.

This episode features Robert L. Page II, PharmD, a professor of clinical pharmacy at the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences and co-author of a recent scientific statement from the American Heart Association (AHA) describing the current state of understanding regarding marijuana and its effect on cardiovascular health.  

For this episode, you will be hearing from Dr. Deepak Bhatt. Dr. Bhatt is the lead author of a recent article published in the Journal of the American Heart Association examining the impact of the ongoing COVID-19 pandemic.  A leading trialist, Dr. Bhatt offers perspective on data and from personal experience on how the pandemic has, is, and will continue to effect clinical trials, with the ripple causing disruptions in treatment pipelines and the treatment of patients.